Clinical Trials Browser

Phase 3 × tanespimycin × Gastrointestinal × Clear all

NCT00688766 2012-12-11

Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib

Phase 3 Terminated

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors